APONTIS PHARMA AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.84 EUR | +1.55% |
|
-2.73% | +67.52% |
| Apr. 05 | Apontis Bags Distribution Deal with Novartis Unit for Two Asthma Medications | MT |
| Mar. 28 | Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Apontis Pharma AG is a Germany-based manufacturer of pharmaceutical preparation. The company focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
Sector
Pharmaceuticals
Calendar
2024-05-07
- Q1 2024 Earnings Call
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
8.14
EUR
Average target price
17.5
EUR
Spread / Average Target
+114.99%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +25.61% | 672B | |
| +25.87% | 570B | |
| -5.24% | 360B | |
| +16.49% | 321B | |
| +8.28% | 300B | |
| +7.09% | 217B | |
| -9.12% | 204B | |
| +5.01% | 199B | |
| -8.75% | 149B |
- Stock Market
- Equities
- APPH Stock
- APPH Stock
- News Apontis Pharma AG
- Apontis Pharma : To Launch New Single Pill For Hypertension, Hyperlipidemia
